title: Hepatitis with cholestasis caused by rivastigmine transdermal patch.
authors.forename: Nicola
authors.initials: N
authors.lastname: Mumoli
authors.forename: Giovanni
authors.initials: G
authors.lastname: Carmignani
authors.forename: Riccardo
authors.initials: R
authors.lastname: Luschi
authors.forename: Marco
authors.initials: M
authors.lastname: Cei
authors.forename: Patrizio
authors.initials: P
authors.lastname: Chiavistelli
mesh_terms: D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D002779:Cholestasis / Q000139:chemically induced* / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D048448:Phenylcarbamates / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D000068836:Rivastigmine; D012720:Severity of Illness Index; D028761:Withholding Treatment
chemical_list: D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine